Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
ISO 28057:2019 Clinical TLD Dosimetry for Radiotherapy
Standardized thermoluminescence detector procedures for photon and electron radiotherapy
ISO 28057:2019 establishes standardized procedures for clinical dosimetry using solid thermoluminescence detectors for photon and electron radiations in radiotherapy. This international standard ensures consistency, accuracy, and traceability of TLD-based dose measurements across radiotherapy centers worldwide, supporting quality assurance programs, enabling intercomparison of treatment delivery accuracy, and providing the technical basis for remote dosimetry audit programs such as those operated by the IAEA and regional dosimetry networks.
TLD dosimetry offers unique advantages for in-vivo dose verification, small-field measurements in stereotactic treatments, and mailed dosimetry audit programs. The small physical size of TLD chips allows measurements in locations inaccessible to larger detectors, including within patient cavities, at tissue interfaces, and in high dose gradient regions.
Measurement Principles and TLD Material Characteristics
The standard covers the fundamental principle of thermoluminescence dosimetry, where ionizing radiation excites electrons to metastable trapped states in crystalline lattice defects. During controlled heating, these trapped electrons return to ground state with emission of visible light proportional to the absorbed dose. ISO 28057 specifies requirements for commonly used TLD materials including LiF:Mg,Ti (TLD-100) and LiF:Mg,Cu,P (TLD-100H), detailing their annealing protocols, energy response characteristics, dose-response linearity range, fading rates, and optimal readout parameters. The standard also addresses the handling and storage conditions necessary to maintain TLD performance.
| TLD Material | Effective Atomic Number | Useful Dose Range | Fading Rate (annual) | Primary Application |
|---|---|---|---|---|
| LiF:Mg,Ti (TLD-100) | 8.2 (tissue-equivalent) | 10 μGy to 10 Gy | Approximately 5% per year | Clinical dosimetry, in-vivo patient verification |
| LiF:Mg,Cu,P (TLD-100H) | 8.2 (tissue-equivalent) | 1 μGy to 30 Gy | Less than 3% per year | Low-dose measurements, high-sensitivity audits |
| CaF2:Dy (TLD-200) | 16.3 (over-response to low energy) | 0.1 μGy to 10 Gy | Approximately 5% per year | Environmental radiation monitoring |
| Al2O3:C (OSL detector) | 10.2 (near-tissue equivalent) | 0.5 μGy to 20 Gy | Less than 1% per year | Personal dosimetry, reference audits |
Energy dependence corrections are critical in TLD clinical dosimetry. While LiF-based detectors are approximately tissue-equivalent for photon energies above 100 keV, they show significant over-response of up to 30% at lower energies. Energy correction factors must be applied when measuring in low-energy photon fields, near tissue interfaces, or in the presence of scattered radiation.
Calibration Protocols and Measurement Procedures
ISO 28057 specifies detailed calibration procedures requiring direct traceability to primary standards dosimetry laboratories through accredited calibration chains. TLD readers must undergo regular quality control including light source stability tests, photomultiplier tube dark current monitoring, heating element temperature profile verification, and annealing oven uniformity checks. The complete measurement procedure encompasses TLD selection and screening, standardized annealing cycles, irradiation following clinical protocols, controlled readout with time-temperature profiles, signal processing with background subtraction, dose calculation using calibration curves with uncertainty propagation, and comprehensive uncertainty analysis following ISO/IEC Guide 98-3.
When ISO 28057 procedures are followed rigorously, TLD dosimetry achieves measurement uncertainties below 2% for photon beams and below 3% for electron beams, supporting both routine quality assurance and reference-level dosimetry audit programs essential for patient safety.
Clinical Applications and International Audit Programs
The standard supports critical clinical applications including in-vivo dosimetry for patient treatment verification, small-field dosimetry for stereotactic radiosurgery and IMRT/VMAT, output constancy checks for linear accelerators, brachytherapy source verification, and inter-institutional dosimetry audits. ISO 28057 serves as the reference standard for the IAEA/WHO TLD postal dose audit program, which has been instrumental in harmonizing radiotherapy dosimetry practices globally for over 50 years.
Q: What advantages do TLDs offer over ionization chambers for clinical dosimetry?
A: TLDs provide high spatial resolution due to small size (typical 3x3x1 mm), require no cables or bias voltage during measurement, can measure in phantoms and patients with minimal perturbation, and exhibit long-term stability suitable for mailed audit programs spanning weeks or months.
A: TLDs provide high spatial resolution due to small size (typical 3x3x1 mm), require no cables or bias voltage during measurement, can measure in phantoms and patients with minimal perturbation, and exhibit long-term stability suitable for mailed audit programs spanning weeks or months.
Q: How frequently should TLD readers undergo calibration?
A: ISO 28057 recommends daily stability checks using a reference light source, monthly calibration verification using reference irradiations, and annual full recalibration at a standards laboratory.
A: ISO 28057 recommends daily stability checks using a reference light source, monthly calibration verification using reference irradiations, and annual full recalibration at a standards laboratory.
Quality Control Program and Routine Performance Verification
A comprehensive quality control program is essential for maintaining TLD dosimetry accuracy. ISO 28057 specifies daily, weekly, monthly, and annual QC procedures. Daily checks include reader warm-up stability test using a reference light source, background reading verification, and annealing oven temperature verification. Weekly procedures include reproducibility testing using a reference irradiation, and annual full recalibration at a standards laboratory. The standard provides action limits for each QC parameter and specifies corrective actions when limits are exceeded.
Inter-laboratory comparison programs are a key requirement of ISO 28057. Each laboratory must participate in at least one external dosimetry audit per year, typically through IAEA or regional audit networks. These comparisons verify that the laboratory’s TLD measurements are consistent with reference values and provide independent validation of the quality control program. Results are analyzed using standardized statistical methods including the well-established En number evaluation.
Q: What actions should be taken when TLD QC checks fail?
A: Immediate corrective actions include repeating the check, verifying reader and oven parameters, checking TLD batch consistency, and if the problem persists, performing preventive maintenance and recalibration. Out-of-specification results should be documented and investigated.
A: Immediate corrective actions include repeating the check, verifying reader and oven parameters, checking TLD batch consistency, and if the problem persists, performing preventive maintenance and recalibration. Out-of-specification results should be documented and investigated.
Q: How are TLD batches validated for homogeneity?
A: New TLD batches must undergo homogeneity testing by irradiating a sample to a known dose and evaluating the coefficient of variation. Batches with CV exceeding 3% may require individual chip calibration factors.
A: New TLD batches must undergo homogeneity testing by irradiating a sample to a known dose and evaluating the coefficient of variation. Batches with CV exceeding 3% may require individual chip calibration factors.
Training Requirements and Personnel Competency
ISO 28057 specifies minimum training and competency requirements for personnel performing TLD dosimetry. Medical physicists and dosimetrists must demonstrate proficiency in TLD handling, readout procedures, calibration techniques, uncertainty analysis, and quality control procedures. The standard recommends documented initial training programs with competency assessment, continuing professional development with minimum annual hours, and periodic proficiency testing through blind audit irradiations.
Clinical Implementation and Patient Safety Impact
TLD dosimetry following ISO 28057 plays a critical role in patient safety for radiotherapy. In-vivo dosimetry using TLDs provides independent verification that the prescribed radiation dose is delivered accurately, detecting errors in treatment planning, machine calibration, or patient setup that could otherwise lead to underdosing of tumors or overdosing of healthy tissues. Many radiotherapy centers have established routine in-vivo TLD programs for specific treatment sites such as breast, head and neck, and prostate treatments.
